Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:ARKF BATS:ARKG BATS:FRDM NYSEARCA:NLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARKFARK Fintech Innovation ETF$53.40+3.3%$45.24$22.85▼$53.56$1.30B1.5437,032 shs1.02 million shsARKGARK Genomic Revolution ETF$24.89+5.4%$23.22$17.51▼$31.16$1.38B1.622.74 million shs4.90 million shsFRDMFreedom 100 Emerging Markets ETF$40.31+22.1%$39.19$30.68▼$41.38$795.11M0.94141,415 shs111,491 shsNLRVanEck Uranium and Nuclear ETF$114.42+2.9%$101.17$64.26▼$114.62$1.84B0.6311,801 shs638,387 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARKFARK Fintech Innovation ETF+3.31%+4.24%+16.24%+64.00%+80.04%ARKGARK Genomic Revolution ETF+2.26%-4.28%+3.99%+20.36%-9.18%FRDMFreedom 100 Emerging Markets ETF+0.59%-0.20%+2.31%+16.71%+9.67%NLRVanEck Uranium and Nuclear ETF+2.86%+8.81%+4.25%+52.93%+36.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARKFARK Fintech Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/AARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AN/AN/AN/AFRDMFreedom 100 Emerging Markets ETFN/AN/AN/AN/AN/AN/AN/AN/ANLRVanEck Uranium and Nuclear ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARKFARK Fintech Innovation ETF 2.62Moderate Buy$53.40N/AARKGARK Genomic Revolution ETF 2.70Moderate Buy$24.89N/AFRDMFreedom 100 Emerging Markets ETF 2.76Moderate Buy$40.31N/ANLRVanEck Uranium and Nuclear ETF 2.79Moderate Buy$114.42N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARKFARK Fintech Innovation ETFN/AN/AN/AN/AN/AN/AARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AN/AFRDMFreedom 100 Emerging Markets ETFN/AN/AN/AN/AN/AN/ANLRVanEck Uranium and Nuclear ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARKFARK Fintech Innovation ETFN/AN/A36.31∞N/AN/AN/AN/AN/AARKGARK Genomic Revolution ETFN/AN/A0.00∞N/AN/AN/AN/AN/AFRDMFreedom 100 Emerging Markets ETFN/AN/A12.68∞N/AN/AN/AN/AN/ANLRVanEck Uranium and Nuclear ETFN/AN/A26.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARKFARK Fintech Innovation ETF$0.180.34%N/AN/AN/AARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AFRDMFreedom 100 Emerging Markets ETF$1.002.48%N/AN/AN/ANLRVanEck Uranium and Nuclear ETF$0.610.53%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARKFARK Fintech Innovation ETFN/AARKGARK Genomic Revolution ETFN/AFRDMFreedom 100 Emerging Markets ETFN/ANLRVanEck Uranium and Nuclear ETFN/AInsider OwnershipCompanyInsider OwnershipARKFARK Fintech Innovation ETFN/AARKGARK Genomic Revolution ETFN/AFRDMFreedom 100 Emerging Markets ETFN/ANLRVanEck Uranium and Nuclear ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARKFARK Fintech Innovation ETFN/A24.30 millionN/ANot OptionableARKGARK Genomic Revolution ETFN/A44.70 millionN/ANot OptionableFRDMFreedom 100 Emerging Markets ETFN/A29.50 millionN/ANot OptionableNLRVanEck Uranium and Nuclear ETFN/A16.04 millionN/ANot OptionableARKG, NLR, FRDM, and ARKF HeadlinesRecent News About These CompaniesETFs to Play on AI's Growing MomentumJuly 14 at 6:16 PM | zacks.comETFs to Watch as SoftBank Eyes $1T Arizona AI hubJune 25, 2025 | zacks.comDisruptive Theme of the Week: Uranium & NuclearJune 17, 2025 | etftrends.comEPower play: Two money managers bet big on uranium, predict long shelf life for gainsJune 14, 2025 | msn.comFunds to play the alternatives tradeJune 11, 2025 | youtube.comYNLR: AI And Clean Energy? Nuclear Is The Key, And Meta Knows ItJune 5, 2025 | seekingalpha.comVanEck Uranium and Nuclear ETF (ARCA:NLR), Short Interest ReportJune 2, 2025 | benzinga.comUranium & Nuclear ETF (NLR) Hits New 52-Week HighMay 28, 2025 | zacks.comETFs to Capitalize on Trump's Orders to Spur Nuclear EnergyMay 23, 2025 | zacks.comOklo, Uranium Energy, NuScale Stocks Surge As Trump Reportedly Gears Up To Boost Nuclear SectorMay 23, 2025 | msn.comNLR: Nuclear Stocks Snap Back, But The Damage Has Been DoneApril 27, 2025 | seekingalpha.comWhy Renewable Energies Will PersistApril 22, 2025 | etftrends.comEIs The 18-Month Low For Uranium Prices Concerning?March 9, 2025 | seekingalpha.comIs This the Perfect Time to Invest in Uranium ETFs?February 27, 2025 | zacks.comNLR: Valuations Seem Overstretched NowFebruary 11, 2025 | seekingalpha.comFriday's ETF Movers: NLR, ITBFebruary 9, 2025 | nasdaq.comDisruptive Theme of the Week: ETF Plays on the Stargate ProjectJanuary 27, 2025 | etftrends.comEHow the (NLR) price action is used to our AdvantageJanuary 27, 2025 | news.stocktradersdaily.comNThis 390-Year-Old Chart Explains Why These 3 Nuclear Stocks Are a Buy Right NowJanuary 24, 2025 | moneymorning.comMNLR: The Math Matters - Energy Demand And The Need For Scalability Point To NuclearJanuary 19, 2025 | seekingalpha.comAI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders (NLR)...January 17, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeARKG, NLR, FRDM, and ARKF Company DescriptionsARK Fintech Innovation ETF NYSEARCA:ARKF$53.40 +1.71 (+3.31%) Closing price 07/16/2025 04:10 PM EasternExtended Trading$53.75 +0.35 (+0.65%) As of 07/16/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ARK Fintech Innovation ETF (ARKF) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund of stocks related to financial technology innovation. ARKF was launched on Feb 4, 2019 and is managed by ARK.ARK Genomic Revolution ETF BATS:ARKG$24.88 +1.28 (+5.40%) Closing price 07/16/2025 03:59 PM EasternExtended Trading$24.78 -0.11 (-0.42%) As of 07/16/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.Freedom 100 Emerging Markets ETF BATS:FRDM$40.30 +7.31 (+22.14%) Closing price 07/16/2025 03:59 PM EasternExtended Trading$40.30 0.00 (0.00%) As of 07/16/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Freedom 100 Emerging Markets ETF (FRDM) is an exchange-traded fund that mostly invests in total market equity. FDRM tracks an index that selects and weights exposure to emerging market equities based on personal and economic freedom metrics. FRDM was launched on May 23, 2019 and is managed by Alpha Architect.VanEck Uranium and Nuclear ETF NYSEARCA:NLR$114.42 +3.18 (+2.86%) As of 07/16/2025 04:10 PM EasternThe VanEck Uranium+Nuclear Energy ETF (NLR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-weighted index of companies in the global nuclear energy industry. NLR was launched on Aug 13, 2007 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
